Vinorelbine: Side Effects, Uses & Monitoring

Facts extracted from current FDA product labeling for Vinorelbine. Educational only — not medical advice.

Labeled uses

Vinorelbine Injection is indicated: In combination with cisplatin for first-line treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) As a single agent for the treatment of patients with metastatic NSCLC

Source: FDA labeling via NIH DailyMed (set 10a70995…). Not affiliated with FDA or NIH.

Medical disclaimer: Always consult a qualified healthcare professional about any medication.

Ratings summarize government-reported measures — they don't capture your personal needs. Visit the facility, ask about staffing and services, and use CMS checklists. This profile is informational only and is not a recommendation.